MUMBAI, (IANS) – Pharma major Lupin Limited has said that it has launched Mirabegron extended-release tablets, 25 mg, in the US market, after having received approval from the Food and Drug ...
Following its FDA approval in the summer, Tonix Pharma's fibromyalgia therapy Tonmya has been launched onto the market in the US, becoming the first new drug for the painful condition in more than 16 ...
A view of the E. Barrett Prettyman U.S. District Court, where Meta Platforms and the Federal Trade Commission are facing off in a trial that could force the company to unwind its acquisitions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results